Created by the Dutch industrialist family Hilekes, in 1993 Medicor expanded beyond the Benelux countries to enter the German-speaking world as Medicor Germany GmbH, selling contrast media injectors for CT, MRI and angiography.
Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have renewed their partnership with the aim of identifying therapeutic targets for treating ‘triple negative’ breast cancers. The partnership will continue for a further three years.
Breast cancer hurt her but after a long treatment, she is now 10 years past the day she heard "You have cancer."
Why is early detection of breast cancer so important? Professor Dr Walter Heindel, Director of the Institute of Clinical Radiology at University Hospital Münster, Germany, offers an unequivocal answer.
It may well be the first computer-aided detection (CAD) software that went to school with radiologists to study breast cancer.
RSNA opens a window for one week where companies can showcase the latest technologies ahead of regulatory approval. Fujifilm seized this opportunity to introduce the leading edge in tomosynthesis, the Amulet Innovality that it has launched in Europe, and that once given the green light by the FDA will come to America under the name Aspire Cristalle.
In May, 2013, the U.S. Food and Drug Administration (FDA) finally took the training wheels off tomosynthesis by approving the use of Hologic's new C-View 2D imaging in place of conventional 2D mammograms previously required as part of a breast tomosynthesis screening exam.
Toshiba ultrasound equipment is helping provide a better oncological and cosmetic outcome for women recovering from breast cancer treatment and surgery. Daniela Zimmermann discussed intraoperative ultrasound-guided breast surgery with surgeon Dr Monique Petrousjka van den Tol, from the Department of Surgical Oncology, VU University Medical Centre in Amsterdam, the Netherlands
In France, every year 15,000 women undergo complete or partial mastectomy due to breast cancer. Only about a third of them, i.e. around 5,000 patients, use the possibilities reconstructive surgery offers and 70 percent of those women opt for an implant although it is associated with a risk of infection because the body might react negatively to the foreign object.
Like any other cancer – breast cancer is a highly individual disease, shaped by many factors such as age, health status or genetics. Due to the complex web of molecular pathological processes and resistance mechanisms it is very difficult to select the most effective therapy for each patient.
Dr Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
Ultrasound may be used during breast conservation surgery, to locate tumour lesions or to place localising wires; it can also guide a lumpectomy and perform a specimen exam to ensure a lesion has been excised and to evaluate surgical margins
Research using an analytical health economics model has suggested the current system of screening within the UK’s National Health Service (NHS) is only moderately likely to be cost effective.
With the help of a commercially available CAD (computer-assisted diagnosis) programme, MRI can provide prognostic data on the development of distant metastases in the further course of breast cancer.
Over the decades of breast imaging numerous studies have shown that radiation free and inexpensive ultrasound can detect some subtle cancers not visible on a mammography exam.
The charity Cancer Research UK reports that the number of breast cancer diagnoses in under 50-year-old women each year in the UK has exceeded 10,000 for the first time.
Self-guided study of more than 6,000 ultrasound exams are at your fingertips thanks to an eight-year voluntary effort by a Dutch radiologist and technical support provided by Hitachi-Aloka.
Israel - Researchers are using breath-test technology to detect volatile organic compounds to tell whether a patient has stomach cancer.
Scientists from the German Cancer Research Center (DKFZ) in Heidelberg have been the first to prove that genetic and environmental risk factors for breast cancer do not act independently of each other.
Times may be tough, but GE Healthcare takes a longer term view, believing innovative technologies can transform healthcare delivery and help improve patient care.
A first in medical imaging is still unknown for Kit Vaughan, who is ready to simultaneously scan with X-rays and ultrasound for breast screening. Stay tuned for the results at RSNA 2013, says EH Correspondent John Brosky
Philips is showcasing the company’s mission of “Transforming Care Together” by featuring several of its latest solutions developed with customer insights in mind, demonstrating the company’s commitment to keeping pace with the changing needs of radiologists at RSNA.
Using advanced microscopes equipped with tissue-penetrating laser light, cancer imaging experts at Johns Hopkins have developed a promising, new way to accurately analyze the distinctive patterns of ultra-thin collagen fibers in breast tumor tissue samples and to help tell if the cancer has spread.
An artificial “brain” built by a 17-year-old whiz kid from Florida is able to accurately assess tissue samples for signs of breast cancer, providing more confidence to a minimally invasive procedure. The cloud-based neural network took top prize in this year’s Google Science Fair.
Cancer specialists everywhere increasingly face new findings from molecular biology. Genetic profiling of tumours opens up entirely new perspectives on the disease. How to cope with and integrate new insights into cancer diagnosis and treatment was among key issues discussed at the 2nd European Forum on Oncology, held in Berlin this May